From: A study of differential microRNA expression profile in migraine: the microMIG exploratory study
ID | KEGG Pathway | Adj. p-value | Target genes |
---|---|---|---|
hsa04020 | Calcium signaling pathway |  < 0.0001 | CACNA1C, HTR2C, PRKCA |
hsa04330 | Notch signaling pathway | 0.001 | DTX4, EP300 |
hsa04750 | Inflammatory mediator regulation of TRP channels | 0.002 | HTR2C, PTGER4, PRKCA |
hsa04720 | Long-term potentiation | 0.002 | CACNA1C, EP300, PRKCA |
hsa05031 | Amphetamine addiction | 0.003 | CACNA1C, PRKCA |
hsa04540 | Gap junction | 0.005 | HTR2C, PRKCA |
hsa04350 | TGF-beta signaling pathway | 0.006 | ID2, ID4, EP300 |
hsa04912 | GnRH signaling pathway | 0.006 | PRKCA, CACNA1C |
hsa04713 | Circadian entrainment | 0.007 | CACNA1C, PRKCA |
hsa04925 | Aldosterone synthesis and secretion | 0.007 | PRKCA, CACNA1C |
hsa04916 | Melanogenesis | 0.008 | EP300, PRKCA |
hsa04066 | HIF-1 signaling pathway | 0.010 | EP300, PRKCA |
hsa04726 | Serotonergic synapse | 0.011 | CACNA1C, HTR2C, PRKCA |
hsa04935 | Growth hormone synthesis, secretion and action | 0.013 | EP300, PRKCA, CACNA1C |
hsa04919 | Thyroid hormone signaling pathway | 0.014 | EP300, PRKCA |
hsa04270 | Vascular smooth muscle contraction | 0.015 | CACNA1C, PRKCA |
hsa04728 | Dopaminergic synapse | 0.018 | PRKCA, CACNA1C |
hsa04261 | Adrenergic signaling in cardiomyocytes | 0.025 | CACNA1C, PRKCA |
hsa04921 | Oxytocin signaling pathway | 0.027 | PRKCA, CACNA1C |
hsa04150 | mTOR signaling pathway | 0.028 | RICTOR, PRKCA |
hsa05161 | Hepatitis B | 0.033 | EP300, PRKCA |
hsa04310 | Wnt signaling pathway | 0.034 | EP300, PRKCA |
hsa05164 | Influenza A | 0.039 | EP300, PRKCA |
hsa05152 | Tuberculosis | 0.046 | EP300, EEA1 |